Argentina |
Marengo et al., 2008 [1717. Marengo MF, Schneeberger EE, Citera G, Cocco JA. Work status among patients with ankylosing spondylitis in Argentina. J Clin Rheumatol. 2008;14: 273-7.] |
61 |
90.2 |
43* |
n/r |
n/r |
100 |
0 |
0 |
0 |
0 |
n/r |
n/r |
|
Bellomio et al., 2008 [1818. Bellomio V, Berman A, Sueldo RR, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Argentina. Reumatol Clin. 2008;4:S23-9.] |
405 |
59 |
48.1 |
71 (W) 23 (WI) |
16.4 |
30.3 |
46.7 |
12.4 |
6.3 |
0.7 |
38.4 |
9.7 |
|
Buschiazzo et al., 2011 [1919. Buschiazzo E, Maldonado-Cocco JA, Arturi P, et al. Epidemiology of spondyloarthritis in Argentina. Am J Med Sci. 2011;341:289-92.] |
402 |
59 |
48.3* |
70.8 (W) 22.8 (WI) |
16.8 |
21.4 |
60.2 |
8.2 |
6.2 |
2.5 |
n/r |
8* |
|
Soriano et al., 2011 [2020. Soriano ER, Rosa J, Velozo E, et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford). 2011;50:729-34.] |
65 |
63.1 |
n/r |
92-96 (W) 2-4 (Asian) |
n/r |
0 |
100 |
0 |
0 |
0 |
40.3 |
8.5 |
|
Schneeberger et al., 2015 [2121. Schneeberger EE, Citera G, Rodriguez Gil G, et al. Clinical and Immunogenetlc characterization in psoriatic arthritis patients. Clin Rheumatol. 2015;34:1413-8.] |
73 |
49.3 |
49* |
n/r |
n/r |
0 |
100 |
0 |
0 |
0 |
43* |
6* |
|
Sommerfleck et al., 2018a [2222. Sommerfleck F, Schneeberger E, Citera G. Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease? Eur J Rheumatol. 2018;5:169-72.] |
86 |
80 |
46* |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
19* |
|
Sommerfleck et al., 2018b [2323. Sommerfleck FA, Schneeberger EE, Orozco MC, Zamora N, Landi M, Citera G. Validation and cultural adaptation of the qualisex questionnaire in patients with axial spondyloarthritis in Argentina. Rheumatol Int. 2018;38:2103-9.] |
50 |
80 |
47* |
n/r |
n/r |
70 |
28 |
0 |
0 |
0 |
n/r |
13* |
|
Scarafia et al., 2016 (CA) [2424. Scarafia S, Duarte V, Romanini FE, et al. Prevalence of overweight and obesity in early psoriatic arthritis clinic. J Clin Rheumatol. 2016;22:139.] |
92 |
46.7 |
47.7 |
n/r |
n/r |
0 |
100 |
0 |
0 |
0 |
n/r |
3 |
|
Capelusnik et al., 2018 (CA) [2525. Capelusnik D, Cavalieri M, Rolón Campuzano R, et al. Prevalence and characteristics of uveitis in a large cohort of patients with axial spondyloarthritis. J Clin Rheumatol. 2018;24:S103-4.] |
231 |
75.3 |
46* |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
20.5* |
Brazil |
Sampaio-Barros et al., 2008 [2626. Sampaio-Barros PD, Gonçalves CR, Braga da Silva JA, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Brasil. Informe del Registro Brasileño de Espondiloartritis. Reumatol Clin. 2008;4:S30-5.] |
1036 |
73.6 |
43.7 |
59.5 (W) 25.9 (AB) |
16.2 |
72.3 |
13.7 |
6.3 |
3.6 |
1.0 |
31 |
12.7 |
|
Skare et al., 2012a [2727. Skare TL, Bortoluzzo AB, Goncalves CR, et al. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol. 2012;39:141-7.] |
1318 |
71.9 |
n/r |
65.0 (W) 31.3 (AB) |
15.9 |
65.1 |
18.3 |
6.8 |
3.5 |
3.5 |
n/r |
14.2 |
|
Skare et al., 2012b [2828. Skare TL, Leite N, Bortoluzzo AB, et al. Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. Clin Exp Rheumatol. 2012;30:351-7.] |
1424 |
75.9 (< 40 y) 60.6 (≥40 y) |
n/r |
n/r |
19.2 (< 40 y) 13.1 (≥40 y) |
66.3 |
18 |
6.7 |
5.5 |
3.5 |
28.6 |
n/r |
|
Rodrigues et al., 2012 [2929. Rodrigues CE, Vieira WP, Bortoluzzo AB, et al. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol. 2012;52:375-83.] |
1472 |
n/r |
n/r |
n/r |
n/r |
65.4 |
18.4 |
6.7 |
3.3 |
3.3 |
n/r |
n/r |
|
Duarte et al., 2014 [3030. Duarte AP, Marques CD, Bortoluzzo AB, et al. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort. Rev Bras Reumatol. 2014;54:424-30.] |
1189 |
70.6 |
44.5 |
57.7 (W) 42.3 (NW) |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
|
Ribeiro et al., 2018 [3131. Ribeiro SLE, de Campos APB, Palominos PE, et al. Different ethnic background is associated with distinct clinical profiles in the spondyloarthritides in the North and South of Brazil. Clin Rheumatol. 2018; 383:195-203.] |
202 |
64.2 |
48.6 |
62.4 (W) 37.6 (NW) |
19.3 |
71.3 |
28.7 |
0 |
0 |
0 |
n/r |
17.2 |
|
Simioni et al., (2019) [3232. Simioni J, Skare TL, Campos APB, et al. Fecal calprotectin, gut inflammation and spondyloarthritis. Arch Med Res. 2019;50:41-6.] |
85 |
64.7% |
49.3* |
76.4% (W) 23.5% (AB) |
n/r |
61.1 |
21.1 |
5.8 |
1.1 |
0 |
n/r |
14* |
|
Henrique et al., 2018 (CA) [3333. Henrique L, Mello A, Kohem C, et al. Psoriatic arthritis patients followed in university hospitals in southern Brazil have a high prevalence of metabolic syndrome, overweight/obesity, diabetes and hypertension. J Clin Rheumatol. 2018;24:S106.] |
82 |
50 |
56 |
n/r |
n/r |
0 |
100 |
0 |
0 |
0 |
n/r |
9.4 |
Chile |
Gutiérrez et al., 2008 [3434. Gutiérrez MA, Pérez C, Saavedra J, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Chile. Reumatol Clin. 2008;4:S41-7.] |
109 |
58.4 |
42 |
16.8 (W) 64.6 (WI) |
13.3 |
58.7 |
25.6 |
7.3 |
0.9 |
5.5 |
35.3 |
7.1 |
|
Ibáñez et al., 2019 (CA) [3535. Ibanez S, van Bentum R, Valenzuela O, van der Horst-Bruisnsma I. Chilean axial spondyloarthritis patients report high disease burden and impaired work activity - an internet survey in 472 patients. Ann Rheum Dis. 2019;78:A477.] |
472 |
36.7 |
42 |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
Colombia |
Valle-Onate et al., 2011 [3636. Valle-Onate R, Candia L, Romero-Sanchez C, et al. Epidemiology of spondyloarthritis in Colombia. Am J Med Sci. 2011;341:293-4.] |
279 |
69.9 |
n/r |
n/r |
n/r |
34.4 |
3.6 |
39.1 |
18.3 |
0.4 |
n/r |
n/r |
|
Bautista-Molano et al., 2016 [3737. Bautista-Molano W, Landewe RB, Londono J, Romero-Sanchez C, Valle-Onate R, van der Heijde D. Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol. 2016;35:1759-67.] |
581 |
71.7 |
35 |
n/r |
5.3 |
29.1 |
3.6 |
39.6 |
26.9 |
0.9 |
28 |
7.3 |
|
Santos et al., 2017 [3838. Santos AM, Pena P, Avila M, et al. Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis. Clin Rheumatol. 2017;36:953-8.] |
189 |
63.8 |
35.9 |
n/r |
n/r |
46.0 |
0 |
35.5 |
18.5 |
0 |
n/r |
n/r |
Costa Rica |
Sáenz Castro et al., 2008 [3939. Sáenz CR. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Costa Rica. Reumatol Clin. 2008;4:S36-40.] |
33 |
57.6 |
41.3 |
21.2 (W) 66.7 (WI) |
12.2 |
45.5 |
6.1 |
45.5 |
0 |
0 |
34.5 |
6.8 |
Mexico |
Casasola-Vargas et al., |
172 |
59.3 |
38.1 |
18.5 (W) |
18.6 |
34.9 |
8.7 |
11.6 |
1.7 |
1.2 |
28.0 |
10.1 |
|
2008 [4040. Casasola-Vargas JC, Flores-Alvarado DE, Huerta-Sil G, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): México. Reumatol Clin. 2008;4:S56-62.] |
|
|
|
76.3 (WI) |
|
|
|
|
|
|
|
|
|
Peláez-Ballestas et al., 2013 [1212. Peláez-Ballestas I, Navarro-Zarza JE, Julian B, et al. A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans. J Clin Rheumatol. 2013;19:57-61.] |
28 |
50 |
40.7 |
n/r |
21.4 |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
Peru |
Chávez-Corrales et al., 2008 [4141. Chávez-Corrales JE, Montero Jáuregui M, Alva Linares M, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Perú. Reumatol Clin. 2008;4: S63-7.] |
60 |
65 |
40.3 |
3.3 (W) 93.3 (WI) |
18.6 |
53 |
6.7 |
13.3 |
1.7 |
0 |
30.6 |
9.7 |
Uruguay |
Palleiro and Spangenberg, 2008 [4242. Palleiro DR, Spangenberg E. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Uruguay. Reumatol Clin. 2008;4:S73-8.] |
53 |
66.0 |
41.2 |
86.8 (W) 11.3 (MR) |
13.2 |
53 |
17 |
19 |
0 |
4 |
31.0 |
10.2 |
Venezuela |
Chacon et al., 2008 [4343. Chacón R, Granados Y, Esteva MH, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Venezuela. Reumatol Clin. 2008;4:S79-86.] |
69 |
62.3 |
40.9 |
31.9 (W) 39.1 (MR) |
27.5 |
55.1 |
21.7 |
11.6 |
0 |
4.3 |
29.4 |
11.5 |
Multinational |
García-Kutzbach et al., 2011 [4444. García-Kutzbach A, Montenegro A, Iraheta I, Bara C, Saenz R. Epidemiology of spondyloarthropathies in Central America. Am J Med Sci. 2011;341:295-7.] |
233 |
46 |
47.5* |
n/r |
n/r |
10 |
9 |
33 |
47.2 |
0.8 |
n/r |
n/r |
|
Benegas et al., 2012 [4545. Benegas M, Munoz-Gomariz E, Font P, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39:2315-20.] |
1083 |
75 |
43 |
n/r |
n/r |
100 |
0 |
0 |
0 |
0 |
28 |
n/r |
|
Bautista-Molano et al., 2018 [4646. Bautista-Molano W, Landewé R, Burgos-Vargas R, et al. Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America: a comparative study with the general population and data from the ASAS-COMOSPA study. J Rheumatol. 2018;45: 206-12.] |
390 |
64 |
45 |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
n/r |
7.0 |